Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucocutaneous Lymph Node Syndrome | 5 | 2023 | 73 | 1.260 |
Why?
|
| Coronary Vessel Anomalies | 10 | 2021 | 282 | 1.100 |
Why?
|
| Coronary Vessels | 6 | 2023 | 531 | 0.940 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 729 | 0.900 |
Why?
|
| Myocarditis | 2 | 2022 | 130 | 0.860 |
Why?
|
| Pericarditis | 1 | 2022 | 42 | 0.740 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2021 | 16 | 0.740 |
Why?
|
| Gastrostomy | 1 | 2021 | 87 | 0.700 |
Why?
|
| Hyperglycemia | 1 | 2022 | 227 | 0.690 |
Why?
|
| Pneumonia, Viral | 2 | 2022 | 377 | 0.670 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 146 | 0.670 |
Why?
|
| Heart Defects, Congenital | 6 | 2025 | 1833 | 0.660 |
Why?
|
| Systemic Inflammatory Response Syndrome | 6 | 2022 | 173 | 0.650 |
Why?
|
| Pulmonary Atresia | 1 | 2019 | 47 | 0.630 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 29 | 0.630 |
Why?
|
| Tracheostomy | 1 | 2021 | 196 | 0.610 |
Why?
|
| Hospitalists | 1 | 2019 | 44 | 0.610 |
Why?
|
| Coronary Circulation | 1 | 2019 | 211 | 0.600 |
Why?
|
| Pneumonia | 1 | 2022 | 325 | 0.600 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2025 | 1123 | 0.590 |
Why?
|
| Vaccination | 3 | 2023 | 961 | 0.590 |
Why?
|
| Child | 36 | 2024 | 24620 | 0.560 |
Why?
|
| Pericardium | 1 | 2017 | 82 | 0.530 |
Why?
|
| Immunoglobulins, Intravenous | 4 | 2023 | 145 | 0.520 |
Why?
|
| Ventricular Function, Left | 5 | 2023 | 514 | 0.520 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 103 | 0.520 |
Why?
|
| Teratoma | 1 | 2017 | 126 | 0.510 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2020 | 259 | 0.480 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 768 | 0.460 |
Why?
|
| Gestational Age | 2 | 2017 | 1169 | 0.450 |
Why?
|
| Fetal Diseases | 1 | 2017 | 457 | 0.410 |
Why?
|
| Connective Tissue Diseases | 2 | 2023 | 30 | 0.410 |
Why?
|
| Hospitalization | 1 | 2021 | 1785 | 0.410 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2023 | 54 | 0.390 |
Why?
|
| Fetal Heart | 3 | 2017 | 120 | 0.380 |
Why?
|
| Coronary Angiography | 6 | 2021 | 449 | 0.380 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2025 | 972 | 0.360 |
Why?
|
| Coronary Aneurysm | 2 | 2023 | 33 | 0.360 |
Why?
|
| Humans | 49 | 2025 | 125138 | 0.340 |
Why?
|
| Infliximab | 2 | 2021 | 66 | 0.340 |
Why?
|
| Child, Preschool | 17 | 2024 | 14155 | 0.330 |
Why?
|
| Aorta, Thoracic | 3 | 2021 | 526 | 0.320 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 2018 | 257 | 0.320 |
Why?
|
| Male | 32 | 2025 | 61465 | 0.310 |
Why?
|
| Echocardiography | 6 | 2025 | 1067 | 0.300 |
Why?
|
| Myocardial Perfusion Imaging | 4 | 2021 | 56 | 0.290 |
Why?
|
| Retrospective Studies | 13 | 2025 | 16350 | 0.280 |
Why?
|
| Female | 30 | 2025 | 66719 | 0.280 |
Why?
|
| Prenatal Diagnosis | 2 | 2025 | 602 | 0.280 |
Why?
|
| Adolescent | 19 | 2024 | 19424 | 0.270 |
Why?
|
| Myocardial Contraction | 2 | 2019 | 265 | 0.270 |
Why?
|
| Infant | 12 | 2024 | 12611 | 0.260 |
Why?
|
| Echocardiography, Doppler | 2 | 2019 | 171 | 0.260 |
Why?
|
| Glucocorticoids | 3 | 2023 | 384 | 0.240 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 3675 | 0.240 |
Why?
|
| Stroke Volume | 3 | 2023 | 496 | 0.240 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 374 | 0.230 |
Why?
|
| Immune System Diseases | 1 | 2025 | 47 | 0.230 |
Why?
|
| Exercise | 2 | 2021 | 814 | 0.230 |
Why?
|
| Coronary Artery Disease | 2 | 2021 | 805 | 0.210 |
Why?
|
| Cardiac Catheterization | 5 | 2020 | 632 | 0.210 |
Why?
|
| Fractional Flow Reserve, Myocardial | 2 | 2021 | 44 | 0.210 |
Why?
|
| Patient Care Team | 2 | 2025 | 542 | 0.210 |
Why?
|
| United States | 10 | 2025 | 10884 | 0.200 |
Why?
|
| Vascular Surgical Procedures | 2 | 2017 | 549 | 0.190 |
Why?
|
| Infant, Newborn | 5 | 2025 | 8275 | 0.190 |
Why?
|
| Disease Management | 3 | 2025 | 528 | 0.180 |
Why?
|
| Aftercare | 1 | 2022 | 146 | 0.180 |
Why?
|
| Shock | 1 | 2022 | 91 | 0.180 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 49 | 0.180 |
Why?
|
| Syncope | 1 | 2021 | 52 | 0.170 |
Why?
|
| Vascular Resistance | 2 | 2018 | 188 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 165 | 0.170 |
Why?
|
| Fever | 2 | 2021 | 298 | 0.170 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2020 | 21 | 0.170 |
Why?
|
| Weight Gain | 1 | 2022 | 400 | 0.160 |
Why?
|
| Time Factors | 5 | 2022 | 6302 | 0.160 |
Why?
|
| Risk Factors | 9 | 2022 | 10284 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2021 | 1172 | 0.160 |
Why?
|
| Liver Transplantation | 2 | 2019 | 1042 | 0.160 |
Why?
|
| Longevity | 1 | 2020 | 135 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 5169 | 0.150 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2019 | 83 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2022 | 493 | 0.150 |
Why?
|
| Sinus of Valsalva | 1 | 2018 | 35 | 0.150 |
Why?
|
| Prospective Studies | 8 | 2024 | 6124 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Cine | 4 | 2021 | 160 | 0.150 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 2182 | 0.150 |
Why?
|
| Pandemics | 2 | 2022 | 1112 | 0.150 |
Why?
|
| MEDLINE | 1 | 2017 | 20 | 0.140 |
Why?
|
| Mitral Valve | 2 | 2016 | 252 | 0.140 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 288 | 0.140 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 3403 | 0.140 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 74 | 0.140 |
Why?
|
| Age Factors | 6 | 2020 | 2815 | 0.140 |
Why?
|
| Myocardial Bridging | 1 | 2017 | 12 | 0.140 |
Why?
|
| Aorta | 2 | 2017 | 545 | 0.130 |
Why?
|
| Incidence | 2 | 2022 | 3133 | 0.130 |
Why?
|
| Diseases in Twins | 1 | 2017 | 94 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 345 | 0.130 |
Why?
|
| Survival Rate | 2 | 2019 | 2051 | 0.130 |
Why?
|
| Computed Tomography Angiography | 4 | 2020 | 198 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2022 | 361 | 0.130 |
Why?
|
| Risk Assessment | 4 | 2020 | 3424 | 0.130 |
Why?
|
| Chest Pain | 1 | 2017 | 129 | 0.130 |
Why?
|
| Aortic Coarctation | 1 | 2017 | 110 | 0.130 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2016 | 112 | 0.130 |
Why?
|
| Steroid Metabolism, Inborn Errors | 1 | 2015 | 3 | 0.130 |
Why?
|
| Pregnancy | 5 | 2025 | 7221 | 0.130 |
Why?
|
| Athletes | 1 | 2016 | 66 | 0.130 |
Why?
|
| Hypertension | 1 | 2024 | 1287 | 0.130 |
Why?
|
| Cholic Acids | 1 | 2015 | 16 | 0.130 |
Why?
|
| Needs Assessment | 1 | 2017 | 174 | 0.120 |
Why?
|
| Drainage | 1 | 2017 | 260 | 0.120 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2015 | 21 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2015 | 41 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 462 | 0.120 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 189 | 0.120 |
Why?
|
| Hemodynamics | 4 | 2022 | 845 | 0.120 |
Why?
|
| Oxygen | 1 | 2018 | 556 | 0.120 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 44 | 0.120 |
Why?
|
| Hyperoxia | 1 | 2016 | 129 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 596 | 0.110 |
Why?
|
| Family | 1 | 2017 | 562 | 0.110 |
Why?
|
| Quality of Life | 2 | 2021 | 1906 | 0.110 |
Why?
|
| Registries | 1 | 2020 | 1434 | 0.110 |
Why?
|
| Texas | 2 | 2019 | 3572 | 0.110 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2015 | 157 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 216 | 0.100 |
Why?
|
| Norwood Procedures | 1 | 2014 | 101 | 0.100 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 515 | 0.090 |
Why?
|
| Adult | 5 | 2024 | 29470 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2017 | 859 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2024 | 4824 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 783 | 0.080 |
Why?
|
| Cardiology | 1 | 2014 | 507 | 0.080 |
Why?
|
| Exercise Test | 2 | 2020 | 254 | 0.080 |
Why?
|
| Receptors, LDL | 2 | 2019 | 88 | 0.070 |
Why?
|
| Biomechanical Phenomena | 2 | 2019 | 243 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2017 | 3050 | 0.060 |
Why?
|
| Triage | 1 | 2025 | 139 | 0.060 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 111 | 0.050 |
Why?
|
| Young Adult | 3 | 2024 | 9060 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 439 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2018 | 1395 | 0.050 |
Why?
|
| Thoracic Surgery | 1 | 2025 | 160 | 0.050 |
Why?
|
| Rivaroxaban | 1 | 2023 | 55 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2024 | 168 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 389 | 0.050 |
Why?
|
| Infant Mortality | 1 | 2022 | 176 | 0.050 |
Why?
|
| Syncope, Vasovagal | 1 | 2021 | 4 | 0.040 |
Why?
|
| Potassium | 1 | 2022 | 284 | 0.040 |
Why?
|
| Prednisolone | 1 | 2021 | 74 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 700 | 0.040 |
Why?
|
| Platelet Count | 1 | 2021 | 137 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2021 | 93 | 0.040 |
Why?
|
| Unconsciousness | 1 | 2021 | 17 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 12276 | 0.040 |
Why?
|
| Sodium | 1 | 2022 | 297 | 0.040 |
Why?
|
| Algorithms | 2 | 2020 | 1630 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 434 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 439 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 693 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2021 | 77 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 206 | 0.040 |
Why?
|
| Aspirin | 1 | 2021 | 222 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 645 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2019 | 69 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2024 | 1351 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 304 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 1 | 2019 | 68 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 576 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2019 | 256 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 81 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 238 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 273 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 127 | 0.040 |
Why?
|
| Umbilical Arteries | 1 | 2018 | 98 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 1391 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2020 | 263 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 317 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 246 | 0.030 |
Why?
|
| Replantation | 1 | 2017 | 55 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 457 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 777 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1275 | 0.030 |
Why?
|
| Critical Care | 1 | 2022 | 656 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2084 | 0.030 |
Why?
|
| Allografts | 1 | 2017 | 176 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2020 | 516 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2021 | 976 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2021 | 500 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1610 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 869 | 0.030 |
Why?
|
| Pregnant Women | 1 | 2016 | 143 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 1893 | 0.030 |
Why?
|
| Heart Septum | 1 | 2015 | 54 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 586 | 0.030 |
Why?
|
| Diastole | 1 | 2015 | 177 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2015 | 112 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1114 | 0.030 |
Why?
|
| Heart Atria | 1 | 2016 | 321 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2014 | 79 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 1307 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2016 | 444 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 338 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 280 | 0.020 |
Why?
|
| Aged | 2 | 2022 | 19666 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2015 | 437 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4685 | 0.020 |
Why?
|
| DNA | 1 | 2015 | 1621 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2878 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2458 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 3015 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 5906 | 0.010 |
Why?
|
| Middle Aged | 1 | 2016 | 26688 | 0.010 |
Why?
|